{"SPADE_N_06048": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_06048", "Sequence": "MSKKQIMSNCISIALLIALIPNIYFIADKMGIQLAPAWYQDIVNWVSAGGTLTTGFAIIVGVTVPAWIAEAAAAFGIASA", "Sequence Length": 80, "Peptide Name": "Sequence 16 from US 20230416797", "Source": "Butyrivibrio fibrisolvens", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "AIG", "Absent Amino Acids": "HORU", "Basic Residues": 3, "Acidic Residues": 3, "Hydrophobic Residues": 52, "Polar Residues": 41, "Positive Residues": 3, "Negative Residues": 3, "Mass": 8383.86, "PI": 5.87, "Net Charge": 0, "Hydrophobicity": 0.99, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00137", "Similarity": 1.0, "Sequence": "IYFIADKMGIQLAPAWYQDIVNWVSAGGTLTTGFAIIVGVTVPAWIAEAAAAFGIASA"}, {"SPADE_ID": "SPADE_UN_01014", "Similarity": 0.5454545454545454, "Sequence": "KKAAAFAAAAAFAAAAFAAAKKKK"}, {"SPADE_ID": "SPADE_UN_03965", "Similarity": 0.5333333333333333, "Sequence": "AAAAAAAAAAAAAAA"}]}}}